NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that revenues for its fiscal fourth quarter rose 24 percent year over year, beating the consensus Wall Street estimate.

The company also reported that revenues for full-year fiscal 2012 increased 23 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.